Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v5-EN
Language English English
Date Updated 2020-06-30 2020-02-29
Drug Identification Number 02401770 02401770
Brand name GENOTROPIN GENOTROPIN
Common or Proper name GENOTROPIN GENOTROPIN
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients SOMATROPIN SOMATROPIN
Strength(s) 0.8MG 0.8MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 7 Pack 7 Pack
ATC code H01AC H01AC
ATC description ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2020-02-28 2020-02-28
Actual start date 2020-03-18
Estimated end date Unknown
Actual end date 2020-06-29
Shortage status Resolved Actual shortage
Company comments Preventatively managing available supply through measured national allocation. Preventatively managing available supply through measured national allocation.
Health Canada comments